Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 6, Issue 2, 2003, Pages 274-381

  Zambito, Ylenia ^a   Di Colo, Giacomo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; CHITOSAN; CHITOSAN DERIVATIVE; DICLOFENAC; MESALAZINE; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; COLON; COLON DISEASE; COLON FLORA; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROHN DISEASE; DISSOLUTION; DRUG ABSORPTION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG PENETRATION; DRUG SOLUBILITY; HYDRODYNAMICS; IN VITRO STUDY; INCUBATION TIME; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PHARMACOKINETICS; RAT; SYNTHESIS; TABLET COMPRESSION; TABLET FORMULATION; TABLET MATRIX; ULCERATIVE COLITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHITIN; CHITOSAN; COLON; DELAYED-ACTION PREPARATIONS; DICLOFENAC; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; MESALAMINE; RATS;

EID: 0141541770     PISSN: 14821826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Yang, L. Chu, J.S. and Fix, J.A., Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm, 235:1-15, 2002.
2. Cole, E.T., Scott, R.A., Connor, A.L., Wilding, I.R., Petereit, H.U., Schminke, C., Beckert, T. and Cadé, D., Enteric coated HPMC capsules designed to achieve intestinal targeting. Int J Pharm, 231:83-95, 2002.
3. Khan, A.K.A., Piris, J. and Truelove, S.C., An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet, 2:892-895, 1977.
4. Peppercorn, M.A., Sulfasalazine: pharmacology, clinical use, toxicity and related new drug development. Ann Intern Med, 3:377-386, 1984.
5. Zuckner, J., International experience with diclofenac in rheumatoid arthritis. Am J Med Suppl 4B:39-42, 1986.
6. Kendall, M.J., Thornhill, D.P. and Willis, J.V., Factors affecting the pharmacokinetics of diclofenac sodium. Rheumatol Rehabilitation Supp,. 2:38-45, 1979.
7. Willis, J.V., Kendall, M.J., Flinn, R.M., Thornhill, D.P. and Welling, P.G.,. The pharmacokinetics of diclofenac sodium following intravenous and oral administration. Eur J Clin Pharmacol, 16:405-410, 1979.
8. Willis, J.V., Kendall, M.J. and Jack, D.B., The influence of food on the absorption of diclofenac after single and multiple oral doses. Eur J Clin Pharmacol, 19:33-37, 1981.
9. Gleiter, C.H., Antonin, K.H., Bieck, P., Godbillon, J., Schönleber W. and Malchow, H., Colonoscopy in the investigation of drug absorption in healthy volunteers. Gastrointest Endosc, 31: 71-73, 1985.
10. Lorenzo-Lamosa, M.L., Remuñán-López, C., Vila-Jato, J.L. and Alonso, M.J., Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Rel, 52:109-118, 1998.
11. Orienti, I., Cerchiara, T., Luppi, B., Bigucci, F., Zuccari, G. and Zecchi, V., Influence of different chitosan salts on the release of sodium diclofenac in colon-specific delivery. Int J Pharm, 238:51-59, 2002.
12. Singla, A.K. and Chawla, M., Chitosan: some pharmaceutical and biological aspects-an update. J Pharm Pharmacol, 53:1047-1067, 2001.
13. Sabnis, S., Rege, P. and Block, L.H., Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. Pharm Dev Technol, 2:243-255, 1997.
14. Haberlin, B. and Friend, D.R., Anatomy and Physiology of the Gastrointestinal Tract: Implication for Colonic Drug Delivery, in: Friend DR (ed), Oral Colon-Specific Drug Delivery, CRC Press, Florida, pp. 1-43, 1992.
15. Khalid, M.N., Ho, L., Agnely, F., Grossiord, J.L. and Couarraze, G., Swelling properties and mechanical characterization of a semi-interpenetrating chitosan/polyethylene oxide network. Comparison with a chitosan reference gel. S.T.P. Pharma Sci, 9:359-364, 1999.
16. Di Colo, G, Zambito, Y, Burgalassi, S, Serafini, A and Saettone, MF, Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). Int J Pharm, 248:115-122, 2002.
17. Carelli, V., Di Colo, G., Nannipieri, E., Poli, B. and Serafini, M.F., Polyoxyethylene poly(methacrylic acid-co-methyl methacrylate) compounds for site-specific peroral delivery. Int J Pharm, 202:103-112, 2000.
18. Di Colo, G., Falchi, S. and Zambito, Y., In vitro evaluation of a system for pH-controlled peroral delivery of metformin. J Control Rel, 80:119-128, 2002.
19. Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, T., Yamamoto, A. and Muranishi, S., Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J Pharm Sci, 86: 1016-1021, 1997.
20. Flynn, G.L., Yalkowsky, S.H. and Roseman, T.J., Mass transport phenomena and models: Theoretical concepts. J Pharm Sci, 63:479-509, 1974.
21. Park, H.S., Lee, J.Y., Cho, S.H., Baek, H.J. and Lee, S.J, Colon delivery of prednisolone based on chitosan coated polysaccharide tablets. Arch Pharm Res, 25:964-968, 2002.